Benoit R M, Naslund M J, Cohen J K
Department of Surgery, Allegheny General Hospital, Pittsburgh, Pennsylvania 15222, USA.
Urology. 2000 Jan;55(1):91-6. doi: 10.1016/s0090-4295(99)00122-3.
Prostate brachytherapy is gaining in popularity among patients and physicians for the treatment of clinically localized prostate cancer. Although several major centers have published their results and morbidity data, nationwide data concerning complications have not been available. This study reports complications after prostate brachytherapy for men in the Medicare population.
All men in the Medicare population who underwent prostate brachytherapy in 1991 were identified. All inpatient, outpatient, and physician (Part B) Medicare claims for these men from 1991 to 1993 were then analyzed to determine outcomes.
In 1991, 2124 men in the Medicare population underwent prostate brachytherapy. A total of 176 men (8.3%) underwent a surgical procedure for bladder outlet obstruction during the follow-up period, including transurethral resection of the prostate in 141 men. Seven men (0.3%) underwent a colostomy for complications secondary to radiation, and 4 men (0.2%) had an artificial urinary sphincter placed after prostate brachytherapy. Penile prostheses were placed in 14 men (0.6%) in the first 24 to 36 months after prostate brachytherapy. A diagnosis of urinary incontinence was carried by 140 men (6.6%) after the procedure; 179 men (8.4%) carried a diagnosis of erectile dysfunction after their procedure. A diagnosis consistent with rectal injury secondary to radiation appeared in 116 men (5.5%) after prostate brachytherapy.
Prostate brachytherapy is being promoted as an effective treatment option for clinically localized prostate cancer that offers a low risk of complications. The low rate of urinary incontinence, bladder outlet obstruction, and erectile dysfunction was confirmed by analyzing a nationwide cohort of men. Rectal complications were also consistent with those described in published studies. The limitations of claim information in determining patient outcomes, however, must be kept in mind when evaluating these data.
前列腺近距离放射治疗在治疗临床局限性前列腺癌方面越来越受到患者和医生的欢迎。尽管几个主要中心已经公布了他们的结果和发病率数据,但尚未有关于并发症的全国性数据。本研究报告了医疗保险人群中男性接受前列腺近距离放射治疗后的并发症情况。
确定了1991年在医疗保险人群中接受前列腺近距离放射治疗的所有男性。然后分析了这些男性在1991年至1993年期间的所有住院、门诊和医生(B部分)医疗保险索赔,以确定结果。
1991年,医疗保险人群中有2124名男性接受了前列腺近距离放射治疗。在随访期间,共有176名男性(8.3%)因膀胱出口梗阻接受了手术,其中141名男性接受了经尿道前列腺切除术。7名男性(0.3%)因放疗并发症接受了结肠造口术,4名男性(0.2%)在前列腺近距离放射治疗后植入了人工尿道括约肌。在前列腺近距离放射治疗后的最初24至36个月内,有14名男性(0.6%)植入了阴茎假体。术后有140名男性(6.6%)被诊断为尿失禁;179名男性(8.4%)术后被诊断为勃起功能障碍。前列腺近距离放射治疗后,116名男性(5.5%)出现了与放疗继发直肠损伤相符的诊断。
前列腺近距离放射治疗被推广为临床局限性前列腺癌的一种有效治疗选择,并发症风险较低。通过分析全国范围内的男性队列,证实了尿失禁、膀胱出口梗阻和勃起功能障碍的发生率较低。直肠并发症也与已发表研究中描述的一致。然而,在评估这些数据时,必须牢记索赔信息在确定患者结果方面的局限性。